These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 8819516)

  • 1. Single-dose hemodynamic toxicity and pharmacokinetics of a partial phosphorothioate anti-HIV oligonucleotide (AR177) after intravenous infusion to cynomolgus monkeys.
    Wallace TL; Bazemore SA; Kornbrust DJ; Cossum PA
    J Pharmacol Exp Ther; 1996 Sep; 278(3):1306-12. PubMed ID: 8819516
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repeat-dose toxicity and pharmacokinetics of a partial phosphorothioate anti-HIV oligonucleotide (AR177) after bolus intravenous administration to cynomolgus monkeys.
    Wallace TL; Bazemore SA; Kornbrust DJ; Cossum PA
    J Pharmacol Exp Ther; 1996 Sep; 278(3):1313-7. PubMed ID: 8819517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toxicity and toxicokinetics of a phosphorothioate oligonucleotide against the c-myc oncogene in cynomolgus monkeys.
    Webb MS; Tortora N; Cremese M; Kozlowska H; Blaquiere M; Devine DV; Kornbrust DJ
    Antisense Nucleic Acid Drug Dev; 2001 Jun; 11(3):155-63. PubMed ID: 11446591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute, multiple-dose, and genetic toxicology of AR177, an anti-HIV oligonucleotide.
    Wallace TL; Gamba-Vitalo C; Loveday KS; Cossum PA
    Toxicol Sci; 2000 Jan; 53(1):63-70. PubMed ID: 10653522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and distribution of a 33P-labeled anti-human immunodeficiency virus oligonucleotide (AR177) after single- and multiple-dose intravenous administration to rats.
    Wallace TL; Bazemore SA; Holm K; Markham PM; Shea JP; Chaudhary N; Cossum PA
    J Pharmacol Exp Ther; 1997 Mar; 280(3):1480-8. PubMed ID: 9067338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of coagulation by a phosphorothioate oligonucleotide.
    Henry SP; Novotny W; Leeds J; Auletta C; Kornbrust DJ
    Antisense Nucleic Acid Drug Dev; 1997 Oct; 7(5):503-10. PubMed ID: 9361909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the toxicity of ISIS 2302, a phosphorothioate oligonucleotide, in a four-week study in cynomolgus monkeys.
    Henry SP; Bolte H; Auletta C; Kornbrust DJ
    Toxicology; 1997 Jun; 120(2):145-55. PubMed ID: 9184201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human immunodeficiency virus glycoprotein gp120 as the primary target for the antiviral action of AR177 (Zintevir).
    Esté JA; Cabrera C; Schols D; Cherepanov P; Gutierrez A; Witvrouw M; Pannecouque C; Debyser Z; Rando RF; Clotet B; Desmyter J; De Clercq E
    Mol Pharmacol; 1998 Feb; 53(2):340-5. PubMed ID: 9463493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complement activation and hemodynamic changes following intravenous administration of phosphorothioate oligonucleotides in the monkey.
    Galbraith WM; Hobson WC; Giclas PC; Schechter PJ; Agrawal S
    Antisense Res Dev; 1994; 4(3):201-6. PubMed ID: 7849490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and metabolism of an oligodeoxynucleotide phosphorothioate (GEM91) in cynomolgus monkeys following intravenous infusion.
    Grindel JM; Musick TJ; Jiang Z; Roskey A; Agrawal S
    Antisense Nucleic Acid Drug Dev; 1998 Feb; 8(1):43-52. PubMed ID: 9512095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preclinical evaluation of the effects of a novel antisense compound targeting C-raf kinase in mice and monkeys.
    Monteith DK; Geary RS; Leeds JM; Johnston J; Monia BP; Levin AA
    Toxicol Sci; 1998 Dec; 46(2):365-75. PubMed ID: 10048140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics and tolerability of intravenous trecovirsen (GEM 91), an antisense phosphorothioate oligonucleotide, in HIV-positive subjects.
    Séréni D; Tubiana R; Lascoux C; Katlama C; Taulera O; Bourque A; Cohen A; Dvorchik B; Martin RR; Tournerie C; Gouyette A; Schechter PJ
    J Clin Pharmacol; 1999 Jan; 39(1):47-54. PubMed ID: 9987700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of Repeated Complement Activation Associated with Chronic Treatment of Cynomolgus Monkeys with 2'-O-Methoxyethyl Modified Antisense Oligonucleotide.
    Shen L; Engelhardt JA; Hung G; Yee J; Kikkawa R; Matson J; Tayefeh B; Machemer T; Giclas PC; Henry SP
    Nucleic Acid Ther; 2016 Aug; 26(4):236-49. PubMed ID: 27140858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of the alternative pathway of complement by a phosphorothioate oligonucleotide: potential mechanism of action.
    Henry SP; Giclas PC; Leeds J; Pangburn M; Auletta C; Levin AA; Kornbrust DJ
    J Pharmacol Exp Ther; 1997 May; 281(2):810-6. PubMed ID: 9152389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complement activation is responsible for acute toxicities in rhesus monkeys treated with a phosphorothioate oligodeoxynucleotide.
    Henry SP; Beattie G; Yeh G; Chappel A; Giclas P; Mortari A; Jagels MA; Kornbrust DJ; Levin AA
    Int Immunopharmacol; 2002 Nov; 2(12):1657-66. PubMed ID: 12469940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A phase I trial of aprinocarsen (ISIS 3521/LY900003), an antisense inhibitor of protein kinase C-alpha administered as a 24-hour weekly infusion schedule in patients with advanced cancer.
    Advani R; Lum BL; Fisher GA; Halsey J; Geary RS; Holmlund JT; Kwoh TJ; Dorr FA; Sikic BI
    Invest New Drugs; 2005 Oct; 23(5):467-77. PubMed ID: 16133798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of high-dose abetimus sodium in normal subjects with specific assessment of effect on coagulation.
    Linnik MD; O'Rourke AM; Crowther MA
    J Clin Pharmacol; 2008 Aug; 48(8):909-18. PubMed ID: 18511650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antisense inhibition of coagulation factor XI prolongs APTT without increased bleeding risk in cynomolgus monkeys.
    Younis HS; Crosby J; Huh JI; Lee HS; Rime S; Monia B; Henry SP
    Blood; 2012 Mar; 119(10):2401-8. PubMed ID: 22246038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oligonucleotides as inhibitors of human immunodeficiency virus.
    Field AK
    Curr Opin Mol Ther; 1999 Jun; 1(3):323-31. PubMed ID: 11713797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preclinical evaluation of the toxicological effects of a novel constrained ethyl modified antisense compound targeting signal transducer and activator of transcription 3 in mice and cynomolgus monkeys.
    Burel SA; Han SR; Lee HS; Norris DA; Lee BS; Machemer T; Park SY; Zhou T; He G; Kim Y; MacLeod AR; Monia BP; Lio S; Kim TW; Henry SP
    Nucleic Acid Ther; 2013 Jun; 23(3):213-27. PubMed ID: 23692080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.